Heartland Group Holdings Limited logo

Ongoing Disclosure Notice – Various

Insider Disclosure23 September 2022HGHFinancials

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

23-Sep-22

Date of last disclosure:

5-Sep-22

Director or senior manager giving disclosure

Full name(s):

Jeffrey Kenneth Greenslade

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Registered Holder and Beneficial Owner

For that relevant interest-

Number held in class before acquisition or disposal:

2,020,855

Number held in class after acquisition or disposal:

2,475,514

Current registered holder(s):

Jeffrey Kenneth Greenslade

Registered holder(s) once transfers are registered:

Not Applicable

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 3

Details of transactions requiring disclosure-
Date of transaction:16 September 202216 September 2022

Nature of transaction:

Issue of shares pursuant to the vesting of

performance rights under the Heartland

Performance Rights Plan 2017, 2018 and

2019 (PR Tranches) for no cash

consideration. Further details of the PR

Tranches are included within Heartland’s

financial statements.

A proportion of the shares issued to Jeffrey

Greenslade pursuant to vesting of the

performance rights were immediately

acquired by Heartland for cash

consideration in order to fund the tax

liability arising for the recipients upon the

issue of shares under the PR Tranches.

More information about this can be found

in the ‘LTI Buyback Disclosure Document’

released on 23 August 2022 and the

Capital Change Noticed released on 19

September 2022 by Heartland.

Name of any other party or parties to the transaction (if known):

Heartland Group Holdings LimitedHeartland Group Holdings Limited

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:Nil$1.83288725 per share

Number of financial products to which the transaction related:

1,064,774415,261

Date of transaction:16 September 2022

Nature of transaction:

An off market transfer of shares

Name of any other party or parties to the transaction (if known):

Sarah Ormond Greenslade

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:Nil

Number of financial products to which the transaction related:

194,854

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:Not applicable

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

Not applicable

Date of the prior written clearance (if any):

Not applicable

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification
I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:23 September 2022

Name and title of authorised person:Phoebe Gibbons, General Counsel


Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

23-Sep-22

Date of last disclosure:

31-Mar-20

Director or senior manager giving disclosure

Full name(s):

Christopher Patrick Francis Flood

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Position held in listed issuer:

Deputy Group Chief Executive Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Registered Holder and Beneficial Owner

For that relevant interest-

Number held in class before acquisition or disposal:

1,576,139

Number held in class after acquisition or disposal:

1,819,706

Current registered holder(s):

Christopher Patrick Francis Flood

Registered holder(s) once transfers are registered:

Not Applicable

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:16 September 202216 September 2022

Nature of transaction:

Issue of shares pursuant to the vesting of

performance rights under the Heartland

Performance Rights Plan 2017, 2018 and

2019 (PR Tranches) for no cash

consideration. Further details of the PR

Tranches are included within Heartland’s

financial statements.

A proportion of the shares issued to

Christopher Flood pursuant to vesting of

the performance rights were immediately

acquired by Heartland for cash

consideration in order to fund the tax

liability arising for the recipients upon the

issue of shares under the PR Tranches.

More information about this can be found

in the ‘LTI Buyback Disclosure Document’

released on 23 August 2022 and the

Capital Change Noticed released on 19

September 2022 by Heartland.

Name of any other party or parties to the transaction (if known):

Heartland Group Holdings LimitedHeartland Group Holdings Limited

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:Nil$1.83288725 per share

Number of financial products to which the transaction related:

399,290155,723

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:Not applicable

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

Not applicable

Date of the prior written clearance (if any):

Not applicable

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:Ordinary shares

Nature of relevant interest:

Registered holder and beneficial owner

For that relevant interest,-

Number held in class:42,360

Current registered holder(s):

Christopher Patrick Francis Flood & Nicola

Anne Moloney & Lane Neave Trustees

Limited

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:23 September 2022

Name and title of authorised person:Phoebe Gibbons, General Counsel


Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

23-Sep-22

Date of last disclosure:

15-Sep-22

Director or senior manager giving disclosure

Full name(s):

Andrew Peter Dixson

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Not Applicable

Position held in listed issuer:

Chief Financial Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Registered Holder and Beneficial Owner

For that relevant interest-

Number held in class before acquisition or disposal:

252,040

Number held in class after acquisition or disposal:

338,796

Current registered holder(s):

Andrew Peter Dixson

Registered holder(s) once transfers are registered:

Not Applicable

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:16 September 202216 September 2022

Nature of transaction:

Issue of shares pursuant to the vesting of

performance rights under the Heartland

Performance Rights Plan 2017, 2018 and

2019 (PR Tranches) for no cash

consideration. Further details of the PR

Tranches are included within Heartland’s

financial statements.

A proportion of the shares issued to

Andrew Dixson pursuant to vesting of the

performance rights were immediately

acquired by Heartland for cash

consideration in order to fund the tax

liability arising for the recipients upon the

issue of shares under the PR Tranches.

More information about this can be found

in the ‘LTI Buyback Disclosure Document’

released on 23 August 2022 and the

Capital Change Noticed released on 19

September 2022 by Heartland.

Name of any other party or parties to the transaction (if known):

Heartland Group Holdings LimitedHeartland Group Holdings Limited

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:Nil$1.83288725 per share

Number of financial products to which the transaction related:

142,22155,465

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:Not applicable

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

Not applicable

Date of the prior written clearance (if any):

Not applicable

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:23 September 2022

Name and title of authorised person:Phoebe Gibbons, General Counsel


Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Heartland Group Holdings Limited

Date this disclosure made:

23-Sep-22

Date of last disclosure:

31-Mar-22

Director or senior manager giving disclosure

Full name(s):

Michael Jonathan Drumm

Name of listed issuer:

Heartland Group Holdings Limited

Name of related body corporate (if applicable):

Position held in listed issuer:

Group Chief Operating Officer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary shares in Heartland Group

Holdings Limited (NZX/ASX: HGH)

Nature of the affected relevant interest(s):

Registered Holder and Beneficial Owner

For that relevant interest-

Number held in class before acquisition or disposal:

18,250

Number held in class after acquisition or disposal:

111,757

Current registered holder(s):

Michael Jonathan Drumm

Registered holder(s) once transfers are registered:

Not Applicable

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

Type of affected derivative:

Not Applicable

Class of underlying financial products:

Details of affected derivative-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not Applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative(if any):

The price specified in the terms of the derivative (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 2

Details of transactions requiring disclosure-
Date of transaction:16 September 202216 September 2022

Nature of transaction:

Issue of shares pursuant to the vesting of

performance rights under the Heartland

Performance Rights Plan 2017, 2018 and

2019 (PR Tranches) for no cash

consideration. Further details of the PR

Tranches are included within Heartland’s

financial statements.

A proportion of the shares issued to

Michael Drumm pursuant to vesting of the

performance rights were immediately

acquired by Heartland for cash

consideration in order to fund the tax

liability arising for the recipients upon the

issue of shares under the PR Tranches.

More information about this can be found

in the ‘LTI Buyback Disclosure Document’

released on 23 August 2022 and the

Capital Change Noticed released on 19

September 2022 by Heartland.

Name of any other party or parties to the transaction (if known):

Heartland Group Holdings LimitedHeartland Group Holdings Limited

The consideration, expressed in New Zealand dollars, paid or recieved for the

acquisition or disposal. If the consideration was not in cash and cannot be readily by

converted into a cash value, describe the consideration:Nil$1.83288725 per share

Number of financial products to which the transaction related:

153,28959,782

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were aquired or disposed of during a closed period:Not applicable

Whether prior written clearance was provided to allow the aquisition or disposal to

proceed during the closed period:

Not applicable

Date of the prior written clearance (if any):

Not applicable

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

Nature of relevant interest:

For that relevant interest,-

Number held in class:

Current registered holder(s):

For a derivative relevant interest,-

Type of derivative:

Details of derivative,-

The notional value of the derivative (if any) or the notional amount of underlying

financial products (if any):

Not applicable

A statement as to whether the derivative is cash settled or physically settled:

Maturity date of the derivative (if any):

Expiry date of the derivative (if any):

The price's specified terms (if any):

Any other details needed to understand how the amount of the consideration payable

under the derivative or the value of the derivative is affected by the value of the

underlying financial products:

For that derivative relevant interest,-

Parties to the derivative:

If the director or senior manager is not a party to the derivative, the nature of the

relevant interest in the derivative:

Cerification

I, certify that, to the best of my knowledge and belief, the information contained in this

disclsoure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:23 September 2022

Name and title of authorised person:Phoebe Gibbons, General Counsel

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • HLG — Hallenstein Glasson Holdings Limited: Directors and Officers Disclosure
    2022-10-03

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Hallenstein Glasson Holdings Limited (HLG) Date this disclosure made: 4-Oct-22 Dat…”

  • THL — Tourism Holdings Limited: Ongoing Disclosure Notices – Multiple
    2022-10-06

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Tourism Holdings Limited Date this disclosure made: 6 October 2022 Date of last di…”

  • AGL — Accordant Group Limited: Ongoing disclosure notice.
    2022-11-20

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Accordant Group Limited Date this disclosure made: 21-Nov-22 Date of last disclosu…”